Detalles de la búsqueda
1.
A multi-institutional randomized phase III study comparing minimally invasive distal pancreatectomy versus open distal pancreatectomy for pancreatic cancer; Japan Clinical Oncology Group study JCOG2202 (LAPAN study).
BMC Cancer
; 24(1): 231, 2024 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38373949
2.
Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger Study).
Gastric Cancer
; 27(3): 580-589, 2024 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38243037
3.
5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer.
Gastric Cancer
; 27(1): 155-163, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37989806
4.
A randomized phase III trial of postoperative surveillance for pathological stage II and IIIA non-small cell lung cancer (JCOG2012, PHOENIX).
Jpn J Clin Oncol
; 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38693750
5.
Prognostic evaluation of the Ki-67 labeling system in histological grading of non-small round cell sarcoma: a supplementary analysis of a randomized controlled trial, JCOG1306.
Jpn J Clin Oncol
; 54(6): 675-680, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38391203
6.
Protocol digest of a randomized controlled adaptive Phase II/III trial of neoadjuvant chemotherapy for Japanese patients with oesophagogastric junction adenocarcinoma: Japan Clinical Oncology Group Study JCOG2203 (NEO-JPEG).
Jpn J Clin Oncol
; 54(2): 206-211, 2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952093
7.
A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904).
Jpn J Clin Oncol
; 54(1): 103-107, 2024 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37801434
8.
Transitional dynamics in oncology clinical trials: evaluating the impact of Clinical Trials Act on cooperative groups.
Jpn J Clin Oncol
; 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38535873
9.
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
Lancet
; 399(10335): 1607-1617, 2022 04 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35461558
10.
Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III trial (JCOG1912, NEW BRIDGE).
BMC Cancer
; 23(1): 1068, 2023 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37932681
11.
Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib.
BMC Cancer
; 23(1): 219, 2023 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36890471
12.
Phase II biomarker identification study of anti-VEGF agents with FOLFIRI for pretreated metastatic colorectal cancer.
Future Oncol
; 19(23): 1593-1600, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37584156
13.
Randomized phase II study comparing neoadjuvant 5-fluorouracil/oxaliplatin/docetaxel versus docetaxel/oxaliplatin/S-1 for patients with type 4 or large type 3 gastric cancer.
Future Oncol
; 19(32): 2147-2155, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37882373
14.
A randomized phase II study comparing preoperative mFOLFOX6 versus FOLFOXIRI for locally advanced colon cancer: JCOG2006.
Future Oncol
; 19(28): 1897-1904, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37750332
15.
Patient-reported outcome and quality of life research policy: Japan Clinical Oncology Group (JCOG) policy.
Jpn J Clin Oncol
; 53(3): 195-202, 2023 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36702740
16.
Definitive S-1/mitomycin-C chemoradiotherapy for stage II/III anal canal squamous cell carcinoma: a phase I/II dose-finding and single-arm confirmatory study (JCOG0903).
Int J Clin Oncol
; 28(8): 1063-1072, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37286878
17.
Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306.
Br J Cancer
; 127(8): 1487-1496, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35871234
18.
The Conventional Technique Versus the No-touch Isolation Technique for Primary Tumor Resection in Patients With Colon Cancer (JCOG1006): A Multicenter, Open-label, Randomized, Phase III Trial.
Ann Surg
; 275(5): 849-855, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35129519
19.
Standardization of evaluation method and prognostic significance of histological response to preoperative chemotherapy in high-grade non-round cell soft tissue sarcomas.
BMC Cancer
; 22(1): 94, 2022 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35062915
20.
A randomized controlled trial comparing perioperative vs. postoperative mFOLFOX6 for lower rectal cancer with suspected lateral pelvic lymph node metastasis (JCOG1310): a phase II/III randomized controlled trial.
Jpn J Clin Oncol
; 52(8): 850-858, 2022 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35640246